Hanekamp Annemarie bought BNTX
May 12, 2026 · Form 4 insider transaction
Hanekamp Annemarie bought 12,586 shares of BioNTech SE at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The exercise price of this option is EUR 89.38. Subject to adjustment such that the trading price of an American Depositary Share ("ADS") as of an exercise date does not exceed 800% of the grant date exercise price.; The option vests annually in equal installments over four years commencing on the first anniversary of the grant date and becomes exercisable four years after the grant date, subject to certain performance-based and other conditions.; The option may be settled in ordinary shares, ADSs and/or cash at the election of the supervisory board.